← All startups
Genmab
Genmab is a publicly traded, international biotechnology company specializing in the creation and development of differentiated antibody therapeutics for the treatment of cancer.
Team23
NameLocationLinksContact
Anthony Pagano
Chief Financial Officer
—
—
Birgitte Stephensen
Executive Vice President
—
—
Bradley Bailey
Executive Vice President
—
—
Christopher Cozic
EVP CPO
—
—
Greg Mueller
EVP General Counsel
—
—
Jan G. J. van de Winkel
President
—
—
Judith Klimovsky
EVP Chief Development Officer
—
—
Martine van Vugt
EVP Chief Strategy Officer
—
—
Rayne Waller
EVP Chief Technical Operations Officer
—
—
Tahamtan Ahmadi
CMO EVP Head of Experimental Medicine
—
—
Dan Zebrowski
Vp
—
—
Leslie C Amendola
Senior Vice President
—
—
Peter Louwagie
Senior Vice President Of Corporate Development…
—
—
Priya Mahale
Chief Of Staff
—
—
Michelle Pleiter
Senior Executive Assistant To The CEO
—
—
Anders Gersel Pedersen
Board Member
—
—
Deirdre P. Connelly
Chair
—
—
Elizabeth O'Farrell
—
—
Martin Schultz
Board Member
—
—
Mijke Zachariasse
Board Member
—
—
Paolo Paoletti
Member of the Board
—
—
Rolf Hoffmann
Board Member
—
—
Takahiro Hamatani
Board Member
—
—